Ra Medical Systems, Inc. delivered its Form 424B1 Prospectus to the U.S. Securities and Exchange Commission on February 7, 2022.The prospectus relates to the offering of 9,535,000 units of Ra Medical Systems, Inc., consisting of one (1) share of common stock, one (1) warrant to purchase one share of their common stock at an exercise…
Ra Medical Systems, the Maker of DABRA Excimer Laser that Produces UVB Photons to Minimize Chemical Compounds in the Body, Submits its Prospectus to SEC
More from InformationalMore posts in Informational »
- UV Business News – Trung T. Doan Now Holds Majority of SEMILeds Common Stock After SEC Filing 13D
- Professional Opion – UVC Is Needed For Public / Health Care Pathogen Disinfection
- Use of Multispectral Imaging Including UV For Reviewing Famous Manuscripts To Find New Text
- NY Governor Hochul Announces $340 M For Local Water Infrastructure Projects
- UV Blood Irradiation To Help Patients Fight Infection